Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | TRPM4 | Q8TD43 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.30 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.30 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2448831 | 0.83 | CYP1A2 (0.44) | PPARGRCE1ALDH1A1HPGDHSD17B10 | |
| SCHEMBL2453098 | 0.80 | ALDH1A1 (0.37) | RCE1ALDH1A1HPGDHSD17B10 | |
| SCHEMBL2453096 | 0.78 | CYP1A2 (0.38) | RCE1ALDH1A1HPGDHSD17B10HSP90AA1 | |
| SCHEMBL7528069 | 0.77 | — | — | |
| SCHEMBL22534075 | 0.77 | ALDH1A1 (0.41) | HDAC4HDAC2HDAC8RCE1ALDH1A1 | |
| SCHEMBL29818226 | 0.77 | ALDH1A1 (0.41) | HDAC4HDAC2HDAC8RCE1ALDH1A1 | |
| SCHEMBL515458 | 0.77 | ALDH1A1 (0.41) | HDAC4HDAC2HDAC8RCE1ALDH1A1 | |
| SCHEMBL14682169 | 0.75 | — | — | |
| SCHEMBL133411 | 0.75 | CYP1A2 (0.39) | HDAC4HDAC2HDAC8RCE1ALDH1A1 | |
| SCHEMBL925882 | 0.73 | CYP1A2 (0.42) | HDAC4HDAC2HDAC8RCE1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8963813-B2 | Organic compound and organic light emitting device having the same | CANON KABUSHIKI KAISHA (JP) | 2015-02-24 | — | — | US | disclosed |
| US-8963813-B2 | Organic compound and organic light emitting device having the same | CANON KABUSHIKI KAISHA (JP) | 2015-02-24 | — | — | US | disclosed |
| US-20130033416-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2013-02-07 | — | — | US | disclosed |
| US-20130033416-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2013-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130033416-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE HAVING THE SAME | TRPA1, OCIAD1, BMP2 | HDAC4 3410/4885HDAC2 2443/4885HDAC8 2839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.